// App-Quantinova.ai

TCT-401 : Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with biOresorbable Scaffolding plaTforms in Europe) Registry

Researchers

Presenter

  • Neil Ruparelia

Principal Investigators

  • Hiroyoshi Kawamoto

  • Davide Capodanno

  • Jens Wiebe

  • Tommaso Gori

  • Holger Nef

  • Julinda Mehilli

  • Maciej Lesiak

  • Giuseppe Caramanno

  • Christoph Naber

  • Carlo Di Mario

  • Piera Capranzano

Medical Centers

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • AOU Careggi, Florence, Italy

  • hospital, Agrigento, Italy

  • Ferrarotto Hospital, Cardiology Division, University of Catania, Catania, Italy

  • Universtitatsklinikum Essen AoR, Essen, Germany

  • The Royal Marsden Hospital, London, United Kingdom

  • San Raffaele Scientific Institute, Milan, Italy

  • Klinik fur Kardiologie und Angiologie, Elisabeth-Krankenhaus, Essen, Germany

  • Poznan University of Medical Sciences, Poznan, Poland

  • Contilia Heart and Vascular Center, Essen, Germany

  • University Hospital, Poznan, Poland

  • Ferrarotto Hospital, Cardiology Division, University of Catania, Catania, Italy

  • University Medical Center Mainz, Mainz, Germany

  • Munich University Clinic, Munich, Germany

  • San Giovanni di Dio Hospital, Agrigento, Italy

  • San Raffaele Scientific Institute/EMO-GVM Centro Cuore Columbus, Milan, Italy

  • Hammersmith Hospital NHS Trust, London, United Kingdom

  • Interventional Cardiology Institute San Raffaele Hospital, Milan, Italy

Locations

  • Poland

  • Germany

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Diabetes

  • Venous thrombosis

  • Coronary Artery Disease

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved